Social Processes Initiative in Neurobiology of Autism-spectrum and Schizophrenia-spectrum Disorders(SPIN-ASD)
Social Processes Initiative in Neurobiology of Autism-spectrum and Schizophrenia-spectrum Disorders(SPIN-ASD)
批准号:
10116181
负责人:
Stephanie H Ameis
金额:
$24.89万
依托单位国家:
美国
项目类别:
财政年份:
2018
资助国家:
美国
项目状态:
已结题
起止时间:
2018-05-01 至 2024-02-29
关键词:
AffectAgeAmygdaloid structureBehavior assessmentBehavioralBiologic DevelopmentBiological MarkersBrainBrain imagingCase-Control StudiesClinicalCognitiveCognitive deficitsDataDiagnosisDiagnosticDimensionsDiseaseEmotionsFundingHeterogeneityImpaired cognitionImpairmentIndividualLeadMethodsMindNeurobiologyNeurocognitiveNeurodevelopmental DisorderOutcomeParietalParticipantPatientsProtocols documentationPsyche structureResearch Domain CriteriaSamplingSiteSocial BehaviorSocial FunctioningSocial ProcessesStratificationStructureSubgroupTherapeuticTherapeutic TrialsTimeVariantYouthadult with autism spectrum disorderautism spectrum disorderbasebiological heterogeneitybrain behaviorclinical Diagnosisclinical heterogeneitycognitive performancecognitive processcohortemerging adultimaging biomarkerimprovedindividuals with autism spectrum disorderinsightmirror neuronneural circuitneural correlateneuroimagingnoveloutcome predictionrecruitrelating to nervous systemschizophrenia-spectrum disordersimulationsocialsocial cognitionsocial deficitssocial relationshipstheoriestherapy development
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY
DESCRIPTION: Social deficits, central to the diagnosis of autism spectrum disorders (ASDs), persist over
time, influence functioning, and are predictive of long-term outcome. However, a range of social impairment
exists among those affected. To date, brain alterations underlying impaired social cognition are not consistently
shown across studies comparing a group of individuals with ASDs, to a group of healthy controls. Similarly,
people with schizophrenia spectrum disorders (SSDs) demonstrate a range of social cognitive impairments
and associated brain alterations have not been consistent. The well-established biological and clinical
heterogeneity of these disorders has, thus far, been a major obstacle to the identification of neural circuit
biomarkers of social cognitive impairment. The Research Domain Criteria (RDoC) approach can capitalize on
clinical and biological heterogeneity to identify novel brain-behavior relationships that may cut across SSD or
ASD diagnoses. Our pilot data show that structural/functional features of key social cognitive circuits are
associated with social cognitive performance along a continuum in healthy controls (HCs), ASDs, and SSDs
(and across a broader range of variation than in HCs and SSDs alone). In the proposed study, we have a
unique opportunity – to recruit a matched sample of individuals with ASDs using identical neuroimaging and
behavioral assessments as implemented at the lead site of an already funded study in HCs and people with
SSDs, within the RDoC Social Processes Domain (1/3R01MH102324). The first aim of our study is to identify
dimensional relationships, among brain circuit structure, brain circuit function, and social cognitive performance
across HCs, participants with SSDs and ASDs. The inclusion of participants with ASDs will enhance variation in
social cognitive performance across our sample and allow us to detect the full range of brain-behavior relationships
that underpin social cognition across HCs, ASDs, and SSDs. Further, we hypothesize that some individuals with
SSDs may be more similarly impaired at the neural circuit and behavioral level to some individuals with ASDs,
as opposed to those within their own diagnostic group. Therefore, we will also apply a novel data-driven
approach, known as Similarity Network Fusion (SNF), to identify subgroups of individuals with similar profiles
of neural circuit and social cognitive impairment that cut across conventional diagnoses. The ultimate aim of the
current proposal is to identify brain-behavior relationships in the Social Processes Domain that cut across DSM
diagnoses, and also parse subsets of people with distinct social cognitive brain-behavior profiles. If successful,
when taken together, these two aims will accelerate mechanism-driven treatment development relevant across
ASDs and SSDs that can improve social function.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: